COVID-19 and other recent events have likely exacerbated stress and depression among teenagers in the United States, who already struggle with mental health stigmas and access to medications and therapies.

Getting the most value out of your specialty drug management partner starts with asking the right questions.

The advancements that will accelerate the delivery of proper treatment, reduce administrative burden, and improve the overall care experience for patients and providers.

All too often, a person’s gender, race, education, income or zip code dictates how healthy they are.

To help clients prepare for the wave of biosimilars on the horizon, we answer some basic questions about these potentially game-changing medications.

Here are three ways plan sponsors can promote and manage the appropriate use of biosimilars to improve drug affordability and access for members.